Radiomics Features Predict Telomerase Reverse Transcriptase Promoter Mutations in World Health Organization Grade II Gliomas via a Machine-Learning Approach
Shengyu Fang(Capital Medical University), Lei Wang(Capital Medical University), Shaowu Li(Capital Medical University), Tao Jiang(Harbin Medical University), Yiming Li(Tianjin Medical University General Hospital), Xing Liu(Capital Medical University), Hong Zhang(Zhejiang Chinese Medical University), Yukun Liu(Anhui Medical University), Yinyan Wang(Chinese Academy of Sciences), Zhiyan Sun(Capital Medical University), Yuchao Liang(Inner Mongolia University), Qiang Zhu(Capital Medical University), Chunyao Zhou(Capital Medical University), Tianshi Li(Capital Medical University), Ziwen Fan(German Cancer Research Center)
Cited by 22
Related Papers
RNA-seq of 272 gliomas revealed a novel, recurrent <i>PTPRZ1-MET</i> fusion transcript in secondary glioblastomas
|Genome Research|2014|425
Phosphoglycerate Kinase 1 Phosphorylates Beclin1 to Induce Autophagy
|Molecular Cell|2017|282
A radiomic signature as a non-invasive predictor of progression-free survival in patients with lower-grade gliomas
|NeuroImage Clinical|2018|262
Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma
|Cancer Discovery|2022|137
Genotype prediction of ATRX mutation in lower-grade gliomas using an MRI radiomics signature
|European Radiology|2018|122